Is COVID-19 infection more severe in kidney transplant recipients?


Journal

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
ISSN: 1600-6143
Titre abrégé: Am J Transplant
Pays: United States
ID NLM: 100968638

Informations de publication

Date de publication:
03 2021
Historique:
received: 28 08 2020
revised: 23 11 2020
accepted: 24 11 2020
pubmed: 2 12 2020
medline: 11 3 2021
entrez: 1 12 2020
Statut: ppublish

Résumé

There are no studies which have compared the risk of severe COVID-19 and related mortality between transplant recipients and nontransplant patients. We enrolled two groups of patients hospitalized for COVID-19, that is, kidney transplant recipients (KTR) from the French Registry of Solid Organ Transplant (n = 306) and a single-center cohort of nontransplant patients (n = 795). An analysis was performed among subgroups matched for age and risk factors for severe COVID-19 or mortality. Severe COVID-19 was defined as admission (or transfer) to an intensive care unit, need for mechanical ventilation, or death. Transplant recipients were younger and had more comorbidities compared to nontransplant patients. They presented with higher creatinine levels and developed more episodes of acute kidney injury. After matching, the 30-day cumulative incidence of severe COVID-19 did not differ between KTR and nontransplant patients; however, 30-day COVID-19-related mortality was significantly higher in KTR (17.9% vs 11.4%, respectively, p = .038). Age >60 years, cardiovascular disease, dyspnea, fever, lymphopenia, and C-reactive protein (CRP) were associated with severe COVID-19 in univariate analysis, whereas transplant status and serum creatinine levels were not. Age >60 years, hypertension, cardiovascular disease, diabetes, CRP >60 mg/L, lymphopenia, kidney transplant status (HR = 1.55), and creatinine level >115 µmol/L (HR = 2.32) were associated with COVID-19-related mortality in univariate analysis. In multivariable analysis, cardiovascular disease, dyspnea, and fever were associated with severe disease, whereas age >60 years, cardiovascular disease, dyspnea, fever, and creatinine level>115 µmol/L retained their independent associations with mortality. KTR had a higher COVID-19-related mortality compared to nontransplant hospitalized patients.

Identifiants

pubmed: 33259686
doi: 10.1111/ajt.16424
pmc: PMC7753418
pii: S1600-6135(22)08464-7
doi:

Substances chimiques

Immunosuppressive Agents 0

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1295-1303

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2020 The American Society of Transplantation and the American Society of Transplant Surgeons.

Références

Crit Care. 2020 Mar 18;24(1):108
pubmed: 32188484
Am J Transplant. 2003 Aug;3(8):977-81
pubmed: 12859532
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Crit Care. 2020 Apr 28;24(1):179
pubmed: 32345311
N Engl J Med. 2020 Jun 18;382(25):2475-2477
pubmed: 32329975
Crit Care. 2020 Jun 18;24(1):356
pubmed: 32552872
J Crit Care. 2011 Dec;26(6):577-85
pubmed: 21489748
PLoS Med. 2020 Sep 10;17(9):e1003321
pubmed: 32911500
Kidney Int. 2020 Jun;97(6):1083-1088
pubmed: 32354634
Cell. 2020 May 28;181(5):1036-1045.e9
pubmed: 32416070
Am J Transplant. 2020 Jul;20(7):1800-1808
pubmed: 32330343
Kidney Int. 2020 May;97(5):829-838
pubmed: 32247631
Kidney Int. 2020 May;97(5):824-828
pubmed: 32204907
Kidney Int. 2005 Feb;67(2):698-705
pubmed: 15673319
Am J Transplant. 2015 Apr;15(4):1101-4
pubmed: 25716741

Auteurs

Sophie Caillard (S)

Department of Nephrology and Transplantation, Strasbourg University Hospital, INSERM, UMR-S 1109, Strasbourg, France.

Nathalie Chavarot (N)

Department of Nephrology and Transplantation, Hôpital Universitaire Necker, APHP Center, Université de Paris INEM INSERM U 1151, CNRS UMR 8253, Paris, France.

Hélène Francois (H)

AP-HP (Assistance Publique-Hôpitaux de Paris), Department of Nephrology and Transplantation, Hopital Tenon, Paris, France.

Marie Matignon (M)

AP-HP, Nephrology and Renal Transplantation Department, Institut Francilien de Recherche en Néphrologie et Transplantation (IFRNT), Groupe Hospitalier Henri-Mondor/Albert-Chenevier, Université Paris-Est-Créteil, (UPEC), DHU (Département Hospitalo-Universitaire) VIC (Virus-Immunité-Cancer), IMRB (Institut Mondor de Recherche Biomédicale), Equipe 21, INSERM U 955, Créteil, France.

Clarisse Greze (C)

Department of Nephrology and Transplantation, Hôpital Bichat, Paris, France.

Nassim Kamar (N)

Department of Nephrology and Transplantation, University of Toulouse, Toulouse, France.

Philippe Gatault (P)

Department of Nephrology and Transplantation, University of Tours, Tours, France.

Olivier Thaunat (O)

Department of Transplantation, Nephrology and Clinical Immunology, Hôpital Edouard Herriot, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, France.

Tristan Legris (T)

Aix Marseille Université, Hôpitaux Universitaires de Marseille, Hôpital Conception, Centre de Néphrologie et Transplantation Rénale, Marseille, France.

Luc Frimat (L)

Department of Nephrology, University of Lorraine, CHRU-Nancy, Vandoeuvre, France.
INSERM CIC-EC CIE6, Nancy, France.

Pierre F Westeel (PF)

Department of Nephrology and Transplantation, University of Amiens, Amiens, France.

Valentin Goutaudier (V)

Department of Nephrology and Transplantation, University of Montpellier, Montpellier, France.

Mariam Jdidou (M)

Department of Nephrology and Transplantation, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.

Renaud Snanoudj (R)

Department of Nephrology and Transplantation, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.

Charlotte Colosio (C)

Department of Nephrology and Transplantation, University of Reims, Reims, France.

Antoine Sicard (A)

Department of Nephrology, Dialysis, and Transplantation, Hopital Pasteur 2, C.H.U. de Nice, Unité de Recherche Clinique Côte d'Azur (UR2CA), Université Côte d'Azur, Nice, France.

Dominique Bertrand (D)

Department of Nephrology and Transplantation, University of Rouen, Rouen, France.

Christiane Mousson (C)

Department of Nephrology and Transplantation, University of Dijon, Dijon, France.

Jamal Bamoulid (J)

Department of Nephrology, University of Besançon, Besançon, France.

Christophe Masset (C)

Department of Nephrology and Transplantation, Center Hospitalier Universitaire de Nantes, Nantes, France.

Antoine Thierry (A)

Department of Nephrology, University of Poitiers, Poitiers, France.

Lionel Couzi (L)

Department of Nephrology-Transplantation-Dialysis-Apheresis, Hôpital Pellegrin, CHU de Bordeaux Pellegrin, Unité Mixte de Recherche "ImmunoConcEpT" 5164 - Université de Bordeaux, Bordeaux, France.

Jonathan M Chemouny (JM)

University of Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) UMR_S 1085, CIC - P 1414, Rennes, France.

Agnes Duveau (A)

Department of Nephrology and Transplantation, University of Angers, Angers, France.

Valerie Moal (V)

Aix Marseille Université, Hôpitaux Universitaires de Marseille, Hôpital Conception, Centre de Néphrologie et Transplantation Rénale, Marseille, France.

Gilles Blancho (G)

Department of Nephrology and Transplantation, Center Hospitalier Universitaire de Nantes, Nantes, France.

Philippe Grimbert (P)

AP-HP, Nephrology and Renal Transplantation Department, Institut Francilien de Recherche en Néphrologie et Transplantation (IFRNT), Groupe Hospitalier Henri-Mondor/Albert-Chenevier, Université Paris-Est-Créteil, (UPEC), DHU (Département Hospitalo-Universitaire) VIC (Virus-Immunité-Cancer), IMRB (Institut Mondor de Recherche Biomédicale), Equipe 21, INSERM U 955, Créteil, France.

Antoine Durrbach (A)

AP-HP, Nephrology and Renal Transplantation Department, Institut Francilien de Recherche en Néphrologie et Transplantation (IFRNT), Groupe Hospitalier Henri-Mondor/Albert-Chenevier, Université Paris-Est-Créteil, (UPEC), DHU (Département Hospitalo-Universitaire) VIC (Virus-Immunité-Cancer), IMRB (Institut Mondor de Recherche Biomédicale), Equipe 21, INSERM U 955, Créteil, France.

Bruno Moulin (B)

Department of Nephrology and Transplantation, Strasbourg University Hospital, INSERM, UMR-S 1109, Strasbourg, France.

Dany Anglicheau (D)

Department of Nephrology and Transplantation, Hôpital Universitaire Necker, APHP Center, Université de Paris INEM INSERM U 1151, CNRS UMR 8253, Paris, France.

Yvon Ruch (Y)

Department of Infectious Diseases, Strasbourg University Hospital, Strasbourg, France.

Charlotte Kaeuffer (C)

Department of Infectious Diseases, Strasbourg University Hospital, Strasbourg, France.

Ilies Benotmane (I)

Department of Nephrology and Transplantation, Strasbourg University Hospital, INSERM, UMR-S 1109, Strasbourg, France.

Morgane Solis (M)

Department of Virology, Strasbourg University Hospital, INSERM, UMR-S 1109, Strasbourg, France.

Yannick LeMeur (Y)

Department of Nephrology, CHU de Brest, UMR1227, Lymphocytes B et Autoimmunité, Université de Brest, Inserm, Labex IGO, Brest, France.

Marc Hazzan (M)

Department of Nephrology and Transplantation, University of Lille, Lille, France.

Francois Danion (F)

Department of Infectious Diseases, Strasbourg University Hospital, Strasbourg, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH